Larimar Therapeutics' CTI-1601 offers hope for Friedreich's ataxia patients, with promising trial results. Check out why LRMR ...

There is no cure, and the disease considerably shortens life expectancy. Friedreich’s ataxia is an inherited disease that affects the nervous system, especially the spinal cord, peripheral ...

Panelists discuss how the differential diagnosis for Friedreich's Ataxia involves distinguishing it from other ataxias, the ...

Most people haven’t heard of the condition, but Friedreich’s ataxia is getting more attention because of a new treatment and ...

Bill Nye, who has helped make science a part of pop culture for a generation of adults and children, is now using his ...

The US biotech’s neurological drug candidate showed a reduction in disease progression of at least 50% and the company will ...

Treatment success was measured as a change from baseline in the modified Friedreich’s Ataxia Rating Scale (mFARS) score. The mFARS is an assessment of neurological function and tests ...

Shares of Biohaven climbed 13% premarket on Monday after the biotech company said its treatment for a rare neurological ...

In order to improve the quality of life of patients with the Ataxia disease, the biotechnological and pharmaceutical industry ...

During the segment, she highlighted the upcoming “On the Move to Cure Ataxia” 5K event, aiming to raise awareness and funds for Ataxia research and support through the National Ataxia Foundation.

A Friedreich ataxia specialist discusses how the typical clinical presentation of Friedreich's Ataxia includes early onset with symptoms such as ataxia and sensory loss, while also examining the ...

European Commission approves OMP Designation for NLX-112 (befiradol) following compelling results in studies funded by the US Dept of De ...